CaraAMathewsMD

Obstetrics & Gynecology • Providence, RI

Gynecologic Oncology

Physician

Join to view full profile

Dr. Mathews is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mathews' full profile

Already have an account?

Office
Women and Infants Hospital
101 Dudley St.
Providence, RI 02905
Phone+1 401-453-7520

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 2009 - 2012
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2005 - 2009
Geisel School of Medicine at DartmouthClass of 2005

Certifications & Licensure

RI State Medical License 2012 - 2026
CT State Medical License 2012 - 2025
MA State Medical License 2012 - 2025
OK State Medical License 2009 - 2015
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2009 Oct 28
Completed
Phase 1
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2011 Mar 14
Completed
Phase 1
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer Start of enrollment: 2012 Oct 01
Completed
Phase 1
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
IMGN853 With Carboplatin in Second-line Treatment of FRα Expressing, Platinum-sensitive Epithelial Ovarian Cancer Start of enrollment: 2022 Sep 28
Active, not recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Invasive acantholytic anaplastic extramammary Paget disease: A previously unreported neoplasm in the vulva and review of the literature.
Flora Mae G Sta Ines, Julia R Salinaro, Mary Marchese, Cara A Mathews, M Ruhul Quddus
Gynecologic Oncology Reports. 2024-12-01
Cost-effectiveness of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a US payer perspective.
Robert L Coleman, Solomon J Lubinga, Qin Shen, Lydia Walder, Mark Burton
Gynecologic Oncology. 2024-11-08
Ever Expanding Morphologic Patterns of Mesonephric-like Adenocarcinomas of the Uterine Corpus: A Report of Two Tumors and a Brief Review of the Literature.
M Ruhul Quddus, Cara A Mathews, Kamaljeet Singh
International Journal of Surgical Pathology. 2024-10-01

Press Mentions

Local Research Contributes to National Standard-of-Care Guidelines for Endometrial CancerApril 24th, 2023
The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024

Professional Memberships

American Society of Clinical Oncology - ASCO
Member